EIP Pharma and Diffusion Pharmaceuticals inks agreement to create CNS-focused company
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
Clinical data to date shows efti uniquely positioned to address entire NSCLC patient population through both chemo-free IO-IO and IO-IO-chemo triple combinations
Launch of the Da Vinci Xi Robotic System is the highlight of the Robotic Colorectal Cancer Symposium organized with the Association of Colon and Rectal Surgeons of India
Getinge has a strong market share in India within several product segments
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
Vijaya Hospital, Chennai adopted Dozee’s AI-based contactless continuous remotemonitoring and early warning system to enhance patient safety
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
The award recognizes and supports promising female scientists working in mass spectrometry
Subscribe To Our Newsletter & Stay Updated